Login / Signup

The gold standard program (GSP) for smoking cessation: a cohort study of its effectiveness among smokers with and without cancer.

Susanne Vahr LauridsenBente Thoft JensenHanne TönnesenSusanne Oksbjerg DaltonMette Rasmussen
Published in: Acta oncologica (Stockholm, Sweden) (2023)
Six percent (2438) of the included smokers were cancer survivors at the time they undertook the GSP. Their 6-month successful quitting showed no difference compared to that of smokers without cancer, neither before nor after adjustment; 35% versus 37% in crude rates and an aOR of 1.13 (95% CI: 0.97-1.32). Likewise, the results for disadvantaged compared to nondisadvantaged cancer survivors were not significantly different (32% versus 33% and an adjusted aOR of 0.87 (95% CI 0.69-1.11)). Overall, an intensive smoking cessation program seems effective in helping both people without cancer and cancer survivors become successful quitters.
Keyphrases
  • smoking cessation
  • replacement therapy
  • papillary thyroid
  • childhood cancer
  • young adults
  • squamous cell
  • randomized controlled trial
  • systematic review
  • quality improvement
  • squamous cell carcinoma